Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-229,451
Closed -$104K 1232
2025
Q2
$104K Buy
229,451
+12,068
+6% +$5.25K ﹤0.01% 1121
2025
Q1
$88.5K Sell
217,383
-3,292
-1% -$2.11K ﹤0.01% 1058
2024
Q4
$146K Sell
220,675
-4,941
-2% -$3.43K ﹤0.01% 1038
2024
Q3
$191K Sell
225,616
-9,100
-4% -$6.96K 0.01% 1093
2024
Q2
$157K Sell
234,716
-1,907
-0.8% -$1.58K 0.01% 976
2024
Q1
$308K Sell
236,623
-945
-0.4% -$990 0.01% 795
2023
Q4
$136K Sell
237,568
-18,382
-7% -$12.7K 0.01% 931
2023
Q3
$193K Sell
255,950
-1,178
-0.5% -$896 0.01% 881
2023
Q2
$188K Sell
257,128
-4,095
-2% -$3.81K 0.01% 895
2023
Q1
$198K Sell
261,223
-7,644
-3% -$7.1K 0.01% 864
2022
Q4
$258K Sell
268,867
-1,458
-0.5% -$2.06K 0.02% 716
2022
Q3
$589K Buy
270,325
+10,546
+4% +$36.4K 0.04% 406
2022
Q2
$909K Buy
259,779
+1,055
+0.4% +$3.94K 0.08% 255
2022
Q1
$1.3M Buy
258,724
+13,073
+5% +$66.2K 0.1% 208
2021
Q4
$1.54M Buy
245,651
+35,349
+17% +$241K 0.11% 177
2021
Q3
$1.67M Buy
210,302
+2,960
+1% +$24.4K 0.14% 150
2021
Q2
$1.55M Buy
+207,342
New +$1.45M 0.1% 215

Other funds holding VXRT

IHT Wealth Management's VXRT Position: Q3 2025 in Review

IHT Wealth Management sold out of Vaxart (VXRT) in Q3 2025, closing a stake of 229,451 shares — an estimated $104K sold.

IHT Wealth Management first reported a position in VXRT in Q2 2021 and held it in 17 quarters. The position peaked at $1.67M in Q3 2021. 17 funds tracked by Wall St. Rank hold VXRT as of Q3 2025.

  • IHT Wealth Management reported no remaining Vaxart position as of Q3 2025 after selling out during the quarter.
  • IHT Wealth Management sold 229,451 Vaxart shares in Q3 2025, an estimated $104K.
  • IHT Wealth Management first reported a position in Vaxart in Q2 2021 and held it in 17 quarters.
  • IHT Wealth Management's Vaxart position peaked at $1.67M in Q3 2021.
  • 17 funds tracked by Wall St. Rank held Vaxart as of Q3 2025.

Based on IHT Wealth Management's 13F filing for Q3 2025, filed 14 Nov 2025.